Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • BPL Medical Technologies Private Ltd announced the acquisition of Penlon Ltd, a UK-based leading global manufacturer of anaesthesia systems and vaporisers with worldwide distribution networks.

  • Young adults who spend more time watching television each day are more likely to obese, says a new research. The research is published online in the journal SAGE Open. The study is a 15-year analysis by the University Of Pittsburgh Graduate School Of Public Health.

  • 11 PC Delhihites suffering from Asthma: Govt

    A survey has found that over 11 per cent people in Delhi are suffering from Asthma and Rhinits, the government today said while acknowledging that air pollution is an "aggravating" factor for respiratory and cardiovascular diseases. "As per a survey conducted by Vallabbhai Patel Chest Institute Delhi in 2006, which covered 5,900 adults belonging to urban, rural and slum population in Delhi, 11.69 per cent were found to be suffering from Rhinits and 11.03 per cent from Asthma," Health Minister J P Nadda informed the Lok °Sabha.

    [adsense:336x280:8701650588]

  • (NewsVoir); The Herbalife Family Foundation (HFF), a non-profit organization dedicated to improving the lives of children by helping charitable organizations provide healthy nutrition to children in need, today announced the launch of the third phase of Casa Herbalife program with Smile Foundation, a national development organization that works for underprivileged children and youth in education, healthcare, livelihoods and women’s empowerment.

  • (NewsVoir); The Herbalife Family Foundation (HFF), a non-profit organization dedicated to improving the lives of children by helping charitable organizations provide healthy nutrition to children in need, today announced the launch of the third phase of Casa Herbalife program with Smile Foundation, a national development organization that works for underprivileged children and youth in education, healthcare, livelihoods and women’s empowerment. During the third phase unveiled today in Bangalore, the HFF will extend grants to provide nutritional support to 1,000 children across India, through Smile Foundation’s ‘Mission Education’ program.

  • Cipla Ltd, a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients, is announced the appointment of Umang Vohra as Global Chief Financial and Strategy Officer and Prabir Jha as Global Chief People Officer effective 1st October 2015.

  • ~ Through the acquisition of InvaGen, Cipla gains scale in the US generics market with a strong manufacturing and R&D base, access to broad product portfolio and a strong customer base consisting of top wholesalers/retailers
    ~ Through the acquisition of Exelan, Cipla gains access to the government and institutional market in the US

    Cipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc. The transaction being subject to certain closing conditions, is valued at $550 million and will be an all cash transaction. The combined revenue from these transactions is over $200 million for the year ended Dec 2014 and over $225 million in LTM June 2015.

  • Voluntary recall of a number of drugs have been initiated by Sun Pharma and Wockhardt from the US market due to different reasons.

    Sun Pharma initiated voluntary recall of multiple lots of Bupropion Hydrochloride Extended-release Tablets USP (SR), 200 mg, 60-count bottle for "failed dissolution specification", while Wockhardt started recalling its Lisinopril Tablets USP, 5 mg and 20 mg for "CGMP violations".

  • One-year-old infant's ability to group objects according to the names associated with them - as opposed to their appearance alone - offers a glimpse into how their vocabulary will develop by the time they are 18 months, shows a new study. The findings will appear in an upcoming issue of the open access journal Frontiers in Psychology.

Subscribe to Pharma News